抑郁症与冠心病的关系

[1] Omega-3augmenta-tion of sertraline in treatment of depression in patients with coro-nary heart disease:a randomized controlled trial. Carney RM,Freedland KE,Rubin EH,et al. The Journal of The American Medical Association . 2009

[2] Membrane Omega-3 Fatty Acid Deficiency as a Preventable Risk Factor for Comorbid Coronary Heart Disease in Major Depressive Disorder[J] . Robert K. McNamara,Radmila M. Manev. &nbspCardiovascular Psychiatry and Neurology . 2009

[3] Decreased platelet nitric oxide synthase activity and plasma nitric oxide metabolites in major depressive disorder. Wendy E. Chrapko Paul Jurasz Marek W. Radomski Nathalie Lara Stephen L. Archer and Jean-Michel Le Mellé,do. Biological Psychology . 2004

[4] Effects of an-tidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. Taylor CB,Youngblood ME,Catellier D,et al. Archives of General Psychiatry . 2005

[5] Influence of depression and effect of treatment with sertraline on quality of life after hospitalization for acute coronary syndrome. Swenson JR,O′Connor CM,Barton D,et al. The American Journal of Cardiology . 2003

[6] Relationship between leftventricular dysfunction and depression following myocardial infarc-tion:data from the MIND-IT. van Melle JP,de Jonge P,Ormel J,et al. European Heart Journal . 2005

[7] Patients with depressive symptoms have lower health status benefits after coronary artery bypass surgery. Mallik,S.,Krumholz,H.M.,Lin,Z.Q. Circulation . 2005

[8] Fatigue, depressive symptoms, and hopelessness as predictors of clinical events following percutaneous coronary intervention with paclitaxel-eluting stents. SS Pedersen,J Denollet,J Daemen. Journal of Psychosomatic Research . 2007

[9] Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment. Pollock,BG,Laghrissi-Thode,F,Wagner,WR. Journal of Clinical Psychopharmacology . 2000

[10] Negative impact of de-pression on outcomes in patients with coronary artery disease:mechanisms,treatment considerations,and future directions. Shimbo D,Davidson KW,Haas DC,et al. International Society on Thrombosis and Haemostasis . 2004

[1] Omega-3augmenta-tion of sertraline in treatment of depression in patients with coro-nary heart disease:a randomized controlled trial. Carney RM,Freedland KE,Rubin EH,et al. The Journal of The American Medical Association . 2009

[2] Membrane Omega-3 Fatty Acid Deficiency as a Preventable Risk Factor for Comorbid Coronary Heart Disease in Major Depressive Disorder[J] . Robert K. McNamara,Radmila M. Manev. &nbspCardiovascular Psychiatry and Neurology . 2009

[3] Decreased platelet nitric oxide synthase activity and plasma nitric oxide metabolites in major depressive disorder. Wendy E. Chrapko Paul Jurasz Marek W. Radomski Nathalie Lara Stephen L. Archer and Jean-Michel Le Mellé,do. Biological Psychology . 2004

[4] Effects of an-tidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. Taylor CB,Youngblood ME,Catellier D,et al. Archives of General Psychiatry . 2005

[5] Influence of depression and effect of treatment with sertraline on quality of life after hospitalization for acute coronary syndrome. Swenson JR,O′Connor CM,Barton D,et al. The American Journal of Cardiology . 2003

[6] Relationship between leftventricular dysfunction and depression following myocardial infarc-tion:data from the MIND-IT. van Melle JP,de Jonge P,Ormel J,et al. European Heart Journal . 2005

[7] Patients with depressive symptoms have lower health status benefits after coronary artery bypass surgery. Mallik,S.,Krumholz,H.M.,Lin,Z.Q. Circulation . 2005

[8] Fatigue, depressive symptoms, and hopelessness as predictors of clinical events following percutaneous coronary intervention with paclitaxel-eluting stents. SS Pedersen,J Denollet,J Daemen. Journal of Psychosomatic Research . 2007

[9] Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment. Pollock,BG,Laghrissi-Thode,F,Wagner,WR. Journal of Clinical Psychopharmacology . 2000

[10] Negative impact of de-pression on outcomes in patients with coronary artery disease:mechanisms,treatment considerations,and future directions. Shimbo D,Davidson KW,Haas DC,et al. International Society on Thrombosis and Haemostasis . 2004